AVAI — what changed in the latest 10-Q
A section-by-section comparison of AVAI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-02-12
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −9 | ~9 | 25 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | Text added/removed | 0 | −1 | ~3 | 52 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
On February 3, 2026, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to change its corporate name from Avant Technologies, Inc. to Avaí Bio, Inc. The Company’s trading symbol will remain “AVAI”, and its CUSIP number wil…
The Company’s name change was announced on FINRA’s Daily List on February 10, 2026, and became effective at the open of business on February 11, 2026. Following the effective date, the Company will operate under the name Avai Bio, Inc.
The total other expenses for the three months ended June 30, 2026 and 2025 were $132,258 and $0, respectively. Other expenses included interest ($43,330) and discount ($47,100) on convertible notes; interest on loan payable ($17,285); and loss on disposal of subsidiary ($24,543). Total other expense…
During the three months ended June 30, 2026 and 2025, net cash flows used in operating activities was $(414,258) and $(240,343), respectively. Cash flows used in operating activities for three months ended June 30, 2026, compared the three months ended June 30, 2025, decreased by $173,915. This decr…
For the three months ended June 30, 2026 and 2025, net cash flows used in investing activities was $(58,600) and $0, respectively. During the three months ended June 30, 2026, net cash from investing activities consisted of API Acquisition costs.
Text removed vs the prior filing · source: 10-Q · 2026-02-12
The total other expenses for the three months ended December 31, 2025 and 2024 were $43,953 and $23,400, respectively. Other expenses included interest and discount on convertible notes. Total other expenses for the three months ended December 31, 2025, compared the three months ended December 31, 2…
Results of Operations for the nine months ended December 31, 2025 and 2024:
For the nine months ended December 31, 2025 and 2024 the Company did not generate any revenue.
Total operating expenses for the nine months ended December 31, 2025 and 2024 were $1,392,029 and $1,571,238. The operating expenses for the nine months ended December 31, 2025, included $19,552 in amortization expenses; $193,910 in consulting services; $600,028 in general and administrative expense…
The total other expenses for the nine months ended December 31, 2025 and 2024 were $102,303 and $34,949, respectively. Other expenses included interest and discount on convertible notes. Total other expenses for nine months ended December 31, 2025, compared the nine months ended December 31, 2024, i…
Risk factors
Text removed vs the prior filing · source: 10-Q · 2026-02-12
The Company had a stockholders’ deficit of $2,794,486 and an accumulated deficit of $5,612,842 as of December 31, 2025.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice